<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd submitted its initial disclosure to BSE under SEBI's Large Corporate framework. The company confirmed it does not qualify as a Large Corporate per the SEBI circular dated October 19, 2023. The filing shows zero outstanding borrowings as of March 31, 2026 (Rs Nil cr). No credit rating is applicable. This is a routine regulatory compliance filing where the company clarifies its non-classification status under the SEBI framework for large corporates with significant borrowings.
This is a routine compliance filing with no direct impact on the stock. The company confirming it has Nil outstanding debt and does not meet Large Corporate criteria indicates it is a smaller entity. No material impact on share price expected.